Elsie Oppermann

1.3k total citations
58 papers, 997 citations indexed

About

Elsie Oppermann is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Elsie Oppermann has authored 58 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Oncology and 13 papers in Immunology. Recurrent topics in Elsie Oppermann's work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Immune Response and Inflammation (7 papers) and Cell Adhesion Molecules Research (7 papers). Elsie Oppermann is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Immune Response and Inflammation (7 papers) and Cell Adhesion Molecules Research (7 papers). Elsie Oppermann collaborates with scholars based in Germany, United States and United Kingdom. Elsie Oppermann's co-authors include Roman A. Blaheta, Wolf O. Bechstein, İngo Marzi, Dietger Jonas, Martin Scholz, A. Encke, Bianca M. Wittig, Jindřich Činátl, Borna Relja and Wolf‐Dietrich Beecken and has published in prestigious journals such as Blood, PLoS ONE and Oncogene.

In The Last Decade

Elsie Oppermann

57 papers receiving 979 citations

Peers

Elsie Oppermann
Shu Sun Denmark
Marilyn M. Giacomini United States
Shoukang Zhu United States
Joon Ho Lee South Korea
A. Beham Germany
Shu Sun Denmark
Elsie Oppermann
Citations per year, relative to Elsie Oppermann Elsie Oppermann (= 1×) peers Shu Sun

Countries citing papers authored by Elsie Oppermann

Since Specialization
Citations

This map shows the geographic impact of Elsie Oppermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsie Oppermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsie Oppermann more than expected).

Fields of papers citing papers by Elsie Oppermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elsie Oppermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsie Oppermann. The network helps show where Elsie Oppermann may publish in the future.

Co-authorship network of co-authors of Elsie Oppermann

This figure shows the co-authorship network connecting the top 25 collaborators of Elsie Oppermann. A scholar is included among the top collaborators of Elsie Oppermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elsie Oppermann. Elsie Oppermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guckelberger, Olaf, Elsie Oppermann, Dhruvajyoti Roy, et al.. (2024). Ezrin Polarization as a Diagnostic Marker for Circulating Tumor Cells in Hepatocellular Carcinoma. Cells. 14(1). 6–6.
2.
Oppermann, Elsie, Andreas A. Schnitzbauer, Philipp Houben, et al.. (2023). Long-term dynamics of extracellular vesicles as recurrence markers in hepatocellular carcinoma patients following surgical tumor resection. Zeitschrift für Gastroenterologie. 61(8). e584–e584. 1 indexed citations
3.
Oppermann, Elsie, Paul K. Ziegler, Katrin Bankov, et al.. (2023). Transglutaminase 2 is associated with adverse colorectal cancer survival and represents a therapeutic target. Cancer Gene Therapy. 30(10). 1346–1354. 14 indexed citations
4.
Schmidt, Jennifer V., Elsie Oppermann, Roman A. Blaheta, et al.. (2021). Carbonic-anhydrase IX expression is increased in thyroid cancer tissue and represents a potential therapeutic target to eradicate thyroid tumor-initiating cells. Molecular and Cellular Endocrinology. 535. 111382–111382. 6 indexed citations
5.
Vogl, Thomas J., Elsie Oppermann, Hanns Ackermann, et al.. (2021). Early dynamic changes in circulating tumor cells and prognostic relevance following interventional radiological treatments in patients with hepatocellular carcinoma. PLoS ONE. 16(2). e0246527–e0246527. 20 indexed citations
6.
Sturm, Ramona, Philipp Störmann, Michel Teuben, et al.. (2018). Comparative Analysis of the Regulatory T Cells Dynamics in Peripheral Blood in Human and Porcine Polytrauma. Frontiers in Immunology. 9. 435–435. 16 indexed citations
7.
Oppermann, Elsie, Nadine Haetscher, Hubert Serve, et al.. (2016). Selective AKT Inhibition by MK-2206 Represses Colorectal Cancer-Initiating Stem Cells. Annals of Surgical Oncology. 23(9). 2849–2857. 27 indexed citations
8.
Tsaur, Igor, Joerg Hennenlotter, Elsie Oppermann, et al.. (2015). PCA3 and PSA gene activity correlates with the true tumor cell burden in prostate cancer lymph node metastases. Cancer Biomarkers. 15(3). 311–316. 5 indexed citations
9.
Oppermann, Elsie, C Blattner, Dirk Henrich, et al.. (2014). Chronic Ethanol Feeding Modulates Inflammatory Mediators, Activation of Nuclear Factor-κB, and Responsiveness to Endotoxin in Murine Kupffer Cells and Circulating Leukocytes. Mediators of Inflammation. 2014. 1–16. 34 indexed citations
10.
Strey, Christoph W., et al.. (2011). Valproate inhibits colon cancer growth through cell cycle modification in vivo and in vitro. Experimental and Therapeutic Medicine. 2(2). 301–307. 9 indexed citations
11.
Boost, Kim Alexander, et al.. (2006). c-Met responsiveness of isolated hepatocytes evaluated in an in vitro de-differentiation model. International Journal of Molecular Medicine. 17(3). 475–82. 3 indexed citations
12.
Maataoui, Adel, Roland Straub, Elsie Oppermann, et al.. (2005). Laserinduzierte interstitielle Thermotherapie (LITT) von Lebermetastasen unterschiedlicher Größe im Kleintiermodell. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 177(3). 405–410. 6 indexed citations
13.
Auth, Marcus, Dirk Woitaschek, Mechthild Beste, et al.. (2005). Preservation of the synthetic and metabolic capacity of isolated human hepatocytes by coculture with human biliary epithelial cells. Liver Transplantation. 11(4). 410–419. 27 indexed citations
14.
Maataoui, Adel, Jun Qian, Martin G. Mack, et al.. (2005). Liver Metastases in Rats: Chemoembolization Combined with Interstitial Laser Ablation for Treatment. Radiology. 237(2). 479–484. 11 indexed citations
15.
Blaheta, Roman A., Wolf‐Dietrich Beecken, Tobias Engl, et al.. (2004). Human Cytomegalovirus Infection of Tumor Cells Downregulates NCAM (CD56): A Novel Mechanism for Virus-Induced Tumor Invasiveness'. Neoplasia. 6(4). 323–331. 32 indexed citations
16.
Blaheta, Roman A., Harilaos Bogossian, Wolf‐Dietrich Beecken, et al.. (2003). Mycophenolate mofetil increases adhesion capacity of tumor cells in vitro1. Transplantation. 76(12). 1735–1741. 14 indexed citations
17.
Blaheta, Roman A., Karen Nelson, Elsie Oppermann, et al.. (2000). MYCOPHENOLATE MOFETIL DECREASES ENDOTHELIAL PROSTAGLANDIN E 2 IN RESPONSE TO ALLOGENEIC T CELLS OR CYTOKINES1. Transplantation. 69(9). 1977–1981. 10 indexed citations
18.
Blaheta, Roman A., Bianca M. Wittig, Elsie Oppermann, et al.. (1999). Mycophenolate mofetil impairs transendothelial migration of allogeneic CD4 and CD8 T-cells. Transplantation Proceedings. 31(1-2). 1250–1252. 69 indexed citations
19.
Blaheta, Roman A., Bernd Kronenberger, Dirk Woitaschek, et al.. (1999). Interference of soluble mediators into liver matrix triggered dedifferentiation of human hepatocytes. Transplantation Proceedings. 31(1-2). 502–504. 6 indexed citations
20.
Blaheta, Roman A., Bianca M. Wittig, Elsie Oppermann, et al.. (1998). Inhibition of endothelial receptor expression and of T-cell ligand activity by mycophenolate mofetil. Transplant Immunology. 6(4). 251–259. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026